Gland Pharma Limited made a strong debut on the Indian stock market, although the injectables-focused firm’s initial public offering had drawn a generally tepid response from retail investors – impacted, in part, by the frosty sentiment towards its Chinese ownership.
India-China Tango: Can Gland Sustain Listing Luster?
Gland Pharma, controlled by Chinese group Fosun, makes shining debut on Indian stock markets despite a lukewarm response to its IPO. Will the buoyant market sentiment sustain amid edgy India-China relations?
